• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于雌激素受体(ER)报告的艾尔雷德评分及其在清晰区分ER阴性和ER阳性乳腺癌方面的影响。

Allred scoring for ER reporting and it's impact in clearly distinguishing ER negative from ER positive breast cancers.

作者信息

Qureshi Asim, Pervez Shahid

机构信息

Department of Pathology, Shaukat Khanum Cancer Hospital, Lahore.

出版信息

J Pak Med Assoc. 2010 May;60(5):350-3.

PMID:20527604
Abstract

OBJECTIVE

To determine the scoring of Estrogen Receptor (ER) status in carcinoma breast by Allred method that is essentially bimodal and to compare the results with a conventional scoring system.

MATERIALS AND METHODS

A retrospective, comparative study carried out at Aga Khan University Hospital Section of Histopathology over a period of 18 months, i.e., Jan 2005 to June 2006. Anti ER antibody (clone D07) was used for all IHC stains using envision detection system. ER stains of 860 consecutive breast cancer cases were reviewed and rescored by both conventional and Allred method of ER scoring.

RESULTS

Comparison of results showed that there was a substantial decrease in weak positive cases from 18% to 5% by rescoring using Allred scoring system compared to conventional scoring. The data was analyzed using chi square test.

CONCLUSION

The sensitivity and specificity of Allred method were calculated; Sensitivity of Allred method was 99.4% & Specificity of Allred method was 99.5% whereas sensitivity and specificity of conventional method was 88.0% and 84% respectively

摘要

目的

采用本质上为双峰的奥尔雷德方法确定乳腺癌中雌激素受体(ER)状态的评分,并将结果与传统评分系统进行比较。

材料与方法

在阿迦汗大学医院组织病理学科室进行了一项为期18个月(即2005年1月至2006年6月)的回顾性比较研究。所有免疫组化染色均使用抗ER抗体(克隆D07)及恩vision检测系统。对860例连续乳腺癌病例的ER染色进行回顾,并采用传统和奥尔雷德ER评分方法重新评分。

结果

结果比较显示,与传统评分相比,使用奥尔雷德评分系统重新评分后,弱阳性病例大幅减少,从18%降至5%。数据采用卡方检验进行分析。

结论

计算了奥尔雷德方法的敏感性和特异性;奥尔雷德方法的敏感性为99.4%,特异性为99.5%,而传统方法的敏感性和特异性分别为88.0%和84%

相似文献

1
Allred scoring for ER reporting and it's impact in clearly distinguishing ER negative from ER positive breast cancers.用于雌激素受体(ER)报告的艾尔雷德评分及其在清晰区分ER阴性和ER阳性乳腺癌方面的影响。
J Pak Med Assoc. 2010 May;60(5):350-3.
2
Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity.雌激素受体抗体孵育时间及乳腺浸润性癌中免疫反应性程度:优化抗体亲和力的重要性
Appl Immunohistochem Mol Morphol. 2007 Jun;15(2):203-7. doi: 10.1097/01.pai.0000209861.90086.58.
3
Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.韩国女性浸润性乳腺癌中激素受体的表达及 3 种抗雌激素受体抗体的比较:使用组织微阵列的多机构回顾性研究。
Am J Surg Pathol. 2012 Dec;36(12):1817-25. doi: 10.1097/PAS.0b013e318267b012.
4
Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases.乳腺癌雌激素受体免疫组化染色结果的双峰频率分布:825例分析
Am J Clin Pathol. 2005 Jan;123(1):16-20. doi: 10.1309/hcf035n9wk40etj0.
5
Immunohistochemical analysis of estrogen receptors in breast carcinomas using monoclonal antibodies that recognize different domains of the receptor molecule.
Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):275-84.
6
Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy.开发用于选择抗激素治疗患者的标准雌激素和孕激素受体免疫组织化学检测方法。
Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):325-31. doi: 10.1097/01.pai.0000213135.16783.bc.
7
The Quantitative ER Immunohistochemical Analysis in Breast Cancer: Detecting the 3 + 0, 4 + 0, and 5 + 0 Allred Score Cases.乳腺癌的定量 ER 免疫组化分析:检测 3+0、4+0 和 5+0 Allred 评分病例。
Medicina (Kaunas). 2019 Aug 10;55(8):461. doi: 10.3390/medicina55080461.
8
Effect of Hydrochloric Acid Decalcification on Expression Pattern of Prognostic Markers in Invasive Breast Carcinomas.盐酸脱钙对浸润性乳腺癌预后标志物表达模式的影响
Appl Immunohistochem Mol Morphol. 2017 Feb;25(2):144-149. doi: 10.1097/PAI.0000000000000277.
9
[Correlation between estrogen receptor status and clinicopathologic parameters in endometrial cancer: a comparative study by immunohistochemistry using different scoring systems].子宫内膜癌中雌激素受体状态与临床病理参数的相关性:使用不同评分系统的免疫组织化学比较研究
Zhonghua Bing Li Xue Za Zhi. 2013 Aug;42(8):509-14.
10
Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies.在雌激素受体阴性和低表达的乳腺癌患者中准确进行雌激素受体定量检测:两项临床研究数据的亚组分析。
Adv Ther. 2019 Apr;36(4):828-841. doi: 10.1007/s12325-019-0896-0. Epub 2019 Mar 11.

引用本文的文献

1
The effects of in ovo administered of monosodium glutamate on the liver development in chicken embyos.在鸡胚中卵内注射味精对肝脏发育的影响。
J Mol Histol. 2025 Jul 31;56(4):244. doi: 10.1007/s10735-025-10529-w.
2
Efficacy and Safety of Chemotherapy Combined with Hormonal Therapy in Heavily Pretreated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ELSA/KGOG3049): A Multicenter Pilot Study.化疗联合激素治疗在多次治疗的晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌中的疗效与安全性(ELSA/KGOG3049):一项多中心试点研究
Cancers (Basel). 2025 Jul 12;17(14):2320. doi: 10.3390/cancers17142320.
3
Female breast cancer trends: A South African perspective.
女性乳腺癌趋势:南非视角
SA J Radiol. 2025 May 31;29(1):3117. doi: 10.4102/sajr.v29i1.3117. eCollection 2025.
4
Successful unconventional precision treatment of inflammatory hormone receptor-positive breast cancer guided by molecular profiling.基于分子图谱指导的炎性激素受体阳性乳腺癌非传统精准治疗成功案例
NPJ Precis Oncol. 2025 Mar 7;9(1):63. doi: 10.1038/s41698-025-00845-5.
5
Clinical and pathological characteristics of HR+ breast cancer with HER2 low and HER2(0) expression: exploring endocrine therapy sensitivity.HR+且HER2低表达及HER2(0)表达的乳腺癌的临床和病理特征:探索内分泌治疗敏感性
Transl Cancer Res. 2024 Dec 31;13(12):6850-6861. doi: 10.21037/tcr-24-1013. Epub 2024 Dec 27.
6
DDX58 deficiency leads to triple negative breast cancer chemotherapy resistance by inhibiting Type I IFN-mediated signalling apoptosis.DDX58缺陷通过抑制I型干扰素介导的信号凋亡导致三阴性乳腺癌化疗耐药。
Front Oncol. 2024 Mar 14;14:1356778. doi: 10.3389/fonc.2024.1356778. eCollection 2024.
7
Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry.通过形态计量学和免疫组织化学研究浸润性乳腺癌中的血管生成。
Med J Armed Forces India. 2022 Jul;78(3):345-354. doi: 10.1016/j.mjafi.2021.10.013. Epub 2021 Dec 16.
8
ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups.雌激素受体β亚型在乳腺癌亚型和亚组中具有不同的临床意义。
Curr Issues Mol Biol. 2022 Apr 6;44(4):1564-1586. doi: 10.3390/cimb44040107.
9
Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects.开展针对乳腺癌亚型的临床前模型研究,以探索治疗前阿司匹林的作用。
Cancer Med. 2022 Oct;11(20):3820-3836. doi: 10.1002/cam4.4756. Epub 2022 Apr 17.
10
Rule-Based Information Extraction from Free-Text Pathology Reports Reveals Trends in South African Female Breast Cancer Molecular Subtypes and Ki67 Expression.基于规则的自由文本病理学报告信息提取揭示了南非女性乳腺癌分子亚型和 Ki67 表达的趋势。
Biomed Res Int. 2022 Jan 20;2022:6157861. doi: 10.1155/2022/6157861. eCollection 2022.